查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1940936

乾眼症治療設備市場：市場洞察、競爭格局與預測（2033 年）

Dry Eye Disease Treatment Devices Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 193 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

受眼部疾病發病率上升和眼部健康意識增強的推動，全球乾眼症治療設備市場正經歷強勁增長。市場預測顯示，該市場規模將從 2026 年的 3,401 億美元成長至 2033 年的 5,587 億美元，複合年增長率 (CAGR) 為 5.20%。乾眼症是由淚液分泌不足或淚液蒸發過多引起的，嚴重影響患者的生活質量，因此迫切需要有效的治療方案。先進的治療設備在醫院、眼科診所和手術機構中日益普及，為患者提供有針對性的非藥物治療選擇。

市場洞察

在技術創新和患者意識不斷提高的推動下，乾眼症治療設備市場正在快速發展。瞼板腺疏通系統、淚小管栓塞器和眼痛緩解設備等設備有助於改善治療效果並提高患者依從性。 此外，微創療法的引入正在減少對傳統藥物的依賴，並有望更快地緩解症狀，帶來更佳的長期療效。數位診斷、人工智慧和遠距醫療解決方案的整合，實現了個人化護理和持續監測，進一步優化了治療。

隨著醫療服務提供者專注於以患者為中心的解決方案，對兼具療效、安全性和便利性的先進設備的需求正在穩步增長。主要產業參與者的研發投入不斷催生創新治療方案，進而支撐著市場的持續成長。

市場驅動因素

以下因素正在推動乾眼症治療設備市場的擴張：

  • 1. 乾眼症盛行率上升：螢幕使用時間增加、人口老化和環境因素導致全球乾眼症發病率上升。
  • 2.技術創新：熱脈動系統、微型剝離工具和淚小管栓塞等先進設備能有效控制乾眼症狀。
  • 3. 提高認知度和早期診斷：患者和醫療保健專業人員越來越重視早期發現和治療，從而推動了對專用設備的需求。
  • 4. 非藥物療法趨勢：與傳統藥物相比，基於設備的治療方法因其副作用更少、依從性更高、症狀緩解更快而備受關注。
  • 5. 醫療保健支出增加：對眼科基礎設施和服務的投資正在推動創新乾眼治療設備的應用。

商機

乾眼治療設備市場為成熟企業和新興企業都提供了龐大的商機。對有效、微創且患者友好的創新設備的需求正在增長。 拓展至新興經濟體，在這些地區，人們對先進眼科護理的認知度和可及性都在不斷提高，這代表著一條關鍵的成長途徑。

策略聯盟、併購預計將推動市場整合，強化產品組合，並支持區域擴張。數位監測、遠距醫療和智慧治療平台的整合也為設備製造商提供了提供全面患者護理的新機會。專注於研發驅動和技術賦能解決方案的公司有望獲得競爭優勢。

區域分析

全球市場在不同地區呈現不同的成長趨勢：

  • 北美：憑藉先進的醫療基礎設施、較高的患者認知度以及主要設備製造商的強大影響力，引領市場。有利的監管框架進一步促進了產品的普及。
  • 歐洲：由於人口老化、乾眼症高發生率以及支持器材治療的報銷政策，歐洲市場呈現穩定成長。
  • 亞太地區：預計成長最快，這主要得益於數位設備使用量的增加、醫療保健投資的擴大以及中國、印度和日本等國家公眾意識的提高。
  • 拉丁美洲：成長的驅動力來自於不斷完善的醫療保健基礎設施以及城市地區先進眼科護理服務的普及。
  • 中東和非洲：儘管市場仍在發展中，但透過教育宣傳活動、政府舉措以及對專業眼科護理服務需求的不斷增長，該市場具有巨大的增長潛力。

主要參與者

乾眼症治療設備市場的競爭格局由專注於產品創新、合作和市場擴張的主要參與者所構成。 主要參與公司包括：

  • Alcon Vision LLC
  • Johnson and Johnson Services Inc.
  • AbbVie Inc.
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals - NuLids LLC
  • 其他

這些公司正在投資研發、新產品發布和區域擴張策略，以鞏固其市場地位，並為全球患者提供尖端解決方案。

市場區隔

乾眼症治療設備市場依類型、原因、應用、最終用戶和地區進行細分：

依類型

  • 瞼板腺疏通系統
  • 淚小點阻塞裝置
  • 止痛裝置
  • 其他

依病因

  • 特發性
  • 罕見疾病
  • 手術
  • 藥物相關
  • 數位產品導致的眼部水分暴露
  • 衰老

依應用

  • 缺水
  • 蒸發

依最終使用者

  • 醫院
  • 眼科診所中心
  • 門診手術中心
  • 其他

依地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

目錄

第一章 摘要整理

第二章：市場概覽

  • 市場定義與細分
  • 市場動態
    • 驅動因素
    • 限制因素
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監理分析
  • 價格趨勢分析
    • 當前價格及未來預測，2025-2033 年
    • 價格影響因素

第三章 全球乾眼症治療設備市場展望，2020-2033 年

  • 全球乾眼症治療設備市場展望，依類型劃分，價值（十億美元），2020-2033 年
    • 瞼板腺疏通系統
    • 淚小點阻塞裝置
    • 止痛裝置
    • 其他
  • 全球乾眼症治療設備市場展望，依病因劃分，價值（十億美元），2020-2033 年
    • 特發性
    • 罕見疾病
    • 手術
    • 藥物相關
    • 數位暴露
    • 衰老
  • 全球乾眼症治療設備市場預測，各用途，金額(10億美元)，2020年～2033年
    • 水分不足
    • 汽化
  • 全球乾眼症治療設備市場預測，各終端用戶，金額(10億美元)，2020年～2033年
    • 醫院
    • 眼科中心
    • 門診病人手術中心
    • 其他
  • 全球乾眼症治療設備市場預測，各地區，金額(10億美元)，2020年～2033年
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第四章 北美乾眼設備市場展望 2020-2033

第五章：歐洲乾眼症設備市場展望，2020-2033

第六章：亞太地區乾眼症設備市場展望，2020-2033

第七章：拉丁美洲乾眼症設備市場展望，2020-2033

第八章：中東與非洲乾眼症設備市場展望，2020-2033

第九章：競爭格局

  • 公司與細分市場熱力圖
  • 公司市佔率分析，2025年
  • 競爭格局概覽
  • 公司簡介
    • 愛爾康視力保健股份有限公司
    • 強生服務公司Inc
    • 艾伯維公司 (AbbVie Inc.)
    • Lumenis Be Ltd
    • ESW - Vision
    • MiBo Medical Group
    • Sight Sciences
    • Eyedetec Medical Inc.
    • BlephEx
    • NuSight Medicals- NuLids LLC

第十章附錄

簡介目錄

The global Dry Eye Disease (DED) Treatment Devices Market is witnessing robust growth, driven by increasing prevalence of ocular disorders and rising awareness of eye health. According to market projections, the market is expected to reach USD 558.7 billion by 2033, growing from USD 340.1 billion in 2026, at a compound annual growth rate (CAGR) of 5.20%. Dry eye disease, a condition caused by insufficient tear production or excessive tear evaporation, significantly impacts quality of life, making effective treatment solutions a critical need. Advanced treatment devices are gaining traction across hospitals, eye care centers, and surgical facilities, providing targeted, non-pharmacological options for patients.

Market Insights

The DED treatment devices market is evolving rapidly, fueled by technological innovation and growing patient awareness. Devices such as meibomian gland unclogging systems, punctal plugs, and ocular pain-relieving instruments are improving treatment outcomes and enhancing patient compliance. In addition, the adoption of minimally invasive therapies is reducing dependence on traditional medications while offering faster relief and better long-term results. Integration of digital diagnostics, artificial intelligence, and telemedicine solutions is further optimizing treatment by enabling personalized care and continuous monitoring.

As healthcare providers increasingly focus on patient-centric solutions, the market is witnessing a steady rise in demand for advanced devices that combine efficacy, safety, and convenience. Research and development investments by key industry players are continuously introducing innovative treatment solutions, positioning the market for sustained growth.

Market Drivers

Several factors are driving the expansion of the DED treatment devices market:

  • 1. Rising Prevalence of Dry Eye Disease: Increasing screen time, aging populations, and environmental factors are contributing to higher incidence of dry eye disease globally.
  • 2. Technological Innovation: Advanced devices such as thermal pulsation systems, microblepharoexfoliation tools, and punctal plugs provide effective management of dry eye symptoms.
  • 3. Growing Awareness and Early Diagnosis: Patients and clinicians are increasingly prioritizing early detection and treatment, creating higher demand for specialized devices.
  • 4. Preference for Non-Pharmacological Treatments: Device-based therapies are gaining traction due to fewer side effects, improved compliance, and faster symptomatic relief compared to conventional medications.
  • 5. Rising Healthcare Expenditure: Investments in ophthalmology infrastructure and eye care services support the adoption of innovative DED treatment devices.

Business Opportunities

The DED treatment devices market presents significant opportunities for both established companies and emerging players. Innovative devices that are effective, minimally invasive, and patient-friendly are in high demand. Expanding into emerging economies, where awareness and access to advanced eye care are improving, represents a key growth avenue.

Strategic partnerships, mergers, and acquisitions are expected to drive market consolidation, enhance product portfolios, and support regional expansion. The integration of digital monitoring, telehealth, and smart treatment platforms also offers new opportunities for device manufacturers to provide comprehensive patient care. Companies that focus on research-driven, technology-enabled solutions are likely to gain a competitive edge.

Regional Analysis

The global market demonstrates varied growth across regions:

  • North America: Leads the market due to advanced healthcare infrastructure, high patient awareness, and strong presence of key device manufacturers. Favorable regulatory frameworks further support adoption.
  • Europe: Exhibits steady growth driven by an aging population, high prevalence of dry eye disease, and reimbursement policies supporting device-based therapies.
  • Asia Pacific: Expected to record the fastest growth, fueled by increased digital device usage, growing healthcare investment, and rising awareness in countries like China, India, and Japan.
  • Latin America: Growth is driven by expanding healthcare infrastructure and urban adoption of advanced ophthalmic treatments.
  • Middle East & Africa: The market is emerging, with growth potential through awareness campaigns, government initiatives, and rising demand for specialized eye care services.

Key Players

The competitive landscape of the DED treatment devices market is shaped by major players focused on product innovation, partnerships, and market expansion. Prominent participants include:

  • Alcon Vision LLC
  • Johnson and Johnson Services Inc
  • AbbVie Inc.
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • Others

These companies are investing in research, new product launches, and regional expansion strategies to strengthen their market position and deliver cutting-edge solutions to patients globally.

Segmentation

The DED treatment devices market is segmented by type, cause, application, end users, and region:

By Type

  • Meibomian Gland Unclogging Devices
  • Punctual Occlusion Devices
  • Pain-Reliving Devices
  • Others

By Cause

  • Idiopathic
  • Rare Diseases
  • Surgery
  • Drug Intake Associated
  • Digital Exposure
  • Age-Related

By Application

  • Aqueous Deficient
  • Evaporative

By End Users

  • Hospitals
  • Eye Care Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 3.1. Global Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Meibomian Gland Unclogging Devices
    • 3.1.2. Punctual Occlusion Devices
    • 3.1.3. Pain-Reliving Devices
    • 3.1.5. Others
  • 3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 3.2.1. Idiopathic
    • 3.2.2. Rare Diseases
    • 3.2.3. Surgery
    • 3.2.4. Drug Intake Associated
    • 3.2.5. Digital Exposure
    • 3.2.6. Age-Related
  • 3.3. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Aqueous Deficient
    • 3.3.2. Evaporative
  • 3.4. Global Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Eye Care Centers
    • 3.4.3. Ambulatory Surgical Centers
    • 3.4.4. Others
  • 3.5. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 4.1. North America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Meibomian Gland Unclogging Devices
    • 4.1.2. Punctual Occlusion Devices
    • 4.1.3. Pain-Reliving Devices
    • 4.1.5. Others
  • 4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 4.2.1. Idiopathic
    • 4.2.2. Rare Diseases
    • 4.2.3. Surgery
    • 4.2.4. Drug Intake Associated
    • 4.2.5. Digital Exposure
    • 4.2.6. Age-Related
  • 4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Aqueous Deficient
    • 4.3.2. Evaporative
  • 4.4. North America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Eye Care Centers
    • 4.4.3. Ambulatory Surgical Centers
    • 4.4.4. Others
  • 4.5. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 4.5.2. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 4.5.3. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 4.5.4. U.S. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 4.5.5. Canada Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 4.5.6. Canada Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 4.5.7. Canada Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 4.5.8. Canada Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Meibomian Gland Unclogging Devices
    • 5.1.2. Punctual Occlusion Devices
    • 5.1.3. Pain-Reliving Devices
    • 5.1.5. Others
  • 5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 5.2.1. Idiopathic
    • 5.2.2. Rare Diseases
    • 5.2.3. Surgery
    • 5.2.4. Drug Intake Associated
    • 5.2.5. Digital Exposure
    • 5.2.6. Age-Related
  • 5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Aqueous Deficient
    • 5.3.2. Evaporative
  • 5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Eye Care Centers
    • 5.4.3. Ambulatory Surgical Centers
    • 5.4.4. Others
  • 5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.2. Germany Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.3. Germany Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.4. Germany Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.5. Italy Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.6. Italy Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.7. Italy Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.8. Italy Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.9. France Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.10. France Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.11. France Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.12. France Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.13. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.14. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.15. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.16. U.K. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.17. Spain Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.18. Spain Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.19. Spain Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.20. Spain Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.21. Russia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.22. Russia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.23. Russia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.24. Russia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.25. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.26. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.27. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.28. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Meibomian Gland Unclogging Devices
    • 6.1.2. Punctual Occlusion Devices
    • 6.1.3. Pain-Reliving Devices
    • 6.1.5. Others
  • 6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 6.2.1. Idiopathic
    • 6.2.2. Rare Diseases
    • 6.2.3. Surgery
    • 6.2.4. Drug Intake Associated
    • 6.2.5. Digital Exposure
    • 6.2.6. Age-Related
  • 6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Aqueous Deficient
    • 6.3.2. Evaporative
  • 6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Eye Care Centers
    • 6.4.3. Ambulatory Surgical Centers
    • 6.4.4. Others
  • 6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.2. China Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.3. China Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.4. China Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.5. Japan Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.6. Japan Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.7. Japan Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.8. Japan Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.9. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.10. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.11. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.12. South Korea Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.13. India Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.14. India Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.15. India Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.16. India Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.17. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.18. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.19. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.20. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.21. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.22. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.23. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.24. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Meibomian Gland Unclogging Devices
    • 7.1.2. Punctual Occlusion Devices
    • 7.1.3. Pain-Reliving Devices
    • 7.1.5. Others
  • 7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 7.2.1. Idiopathic
    • 7.2.2. Rare Diseases
    • 7.2.3. Surgery
    • 7.2.4. Drug Intake Associated
    • 7.2.5. Digital Exposure
    • 7.2.6. Age-Related
  • 7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Aqueous Deficient
    • 7.3.2. Evaporative
  • 7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Eye Care Centers
    • 7.4.3. Ambulatory Surgical Centers
    • 7.4.4. Others
  • 7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.2. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.3. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.4. Brazil Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 7.5.5. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.6. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.7. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.8. Mexico Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 7.5.9. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.10. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.11. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.12. Argentina Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 7.5.13. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.14. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.15. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.16. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Meibomian Gland Unclogging Devices
    • 8.1.2. Punctual Occlusion Devices
    • 8.1.3. Pain-Reliving Devices
    • 8.1.5. Others
  • 8.2. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 8.2.1. Idiopathic
    • 8.2.2. Rare Diseases
    • 8.2.3. Surgery
    • 8.2.4. Drug Intake Associated
    • 8.2.5. Digital Exposure
    • 8.2.6. Age-Related
  • 8.3. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Aqueous Deficient
    • 8.3.2. Evaporative
  • 8.4. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Eye Care Centers
    • 8.4.3. Ambulatory Surgical Centers
    • 8.4.4. Others
  • 8.5. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.2. GCC Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.3. GCC Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.4. GCC Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.5. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.6. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.7. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.8. South Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.9. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.10. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.11. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.12. Egypt Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.13. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.14. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.15. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.16. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.17. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.18. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.19. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.20. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Alcon Vision LLC
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Johnson and Johnson Services Inc
    • 9.4.3. AbbVie Inc.
    • 9.4.4. Lumenis Be Ltd
    • 9.4.5. ESW - Vision
    • 9.4.6. MiBo Medical Group
    • 9.4.7. Sight Sciences
    • 9.4.8. Eyedetec Medical Inc.
    • 9.4.9. BlephEx
    • 9.4.10. NuSight Medicals- NuLids LLC

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations